IMNM
Immunome Inc
22.30$
-7.8%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 98.1% | 97.4% | 98.0% | 96.0% | 95.0% | 92.1% | 94.3% | 93.6% | 93.5% | 96.7% | 95.9% | 95.2% | |
| 97.3% | 66.4% | 84.4% | 55.8% | 60.6% | 59.7% | 75.2% | 48.6% | 91.1% | 95.7% | 94.0% | 38.5% | |
| 97.3% | 93.0% | 96.9% | 94.0% | 93.5% | 90.5% | 92.6% | 90.5% | 91.1% | 95.7% | 94.0% | 92.0% | |
| 0.0% | 0.2% | – | – | – | – | – | – | – | – | – | – | |
| 93.5% | 19.3% | 10.7% | 14.3% | 16.3% | 24.6% | 10.4% | 9.1% | 11.8% | 7.1% | 5.0% | 7.1% | |
| 24.8% | 14.7% | 9.6% | 13.5% | 15.4% | 22.6% | 9.0% | 7.7% | 10.5% | 6.6% | 4.4% | 6.3% | |
| 0.3% | 0.2% | 0.1% | 0.1% | 0.1% | 0.0% | – | – | – | – | – | – | |
| 3.0% | 2.2% | 2.2% | 2.4% | 1.4% | 5.9% | 2.7% | 1.6% | 2.1% | 0.5% | 0.9% | 1.1% | |
| 6.5% | 80.7% | 89.3% | 85.7% | 83.7% | 75.4% | 89.6% | 90.9% | 88.2% | 92.9% | 95.0% | 92.9% | |
| -139.7% | -150.0% | -110.2% | -131.1% | -169.5% | -214.7% | -162.7% | -202.8% | -219.9% | -106.6% | -126.2% | -151.2% | |
| 13.1% | 14.8% | 3.2% | 20.2% | 23.4% | 26.1% | 23.2% | 29.4% | 29.4% | 12.8% | 18.3% | 20.0% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.